Content uploaded by Marina Lobato Martins
Author content
All content in this area was uploaded by Marina Lobato Martins on Oct 28, 2015
Content may be subject to copyright.
Available via license: CC BY 2.0
Content may be subject to copyright.
POSTER PRESENTATION Open Access
Follow-up of HTLV-1 positive individuals in the
GIPH cohort (1997-2013): Proviral load was not a
prognostic marker for HAM/TSP
Poliane C Gonçalves
1
, Gabriela S Freitas
1,2*
, Luiz CF Romanelli
1
, Fernando A Proietti
1
, Anna B Carneiro-Proietti
1
,
Marina L Martins
1
From 16th International Conference on Human Retroviruses: HTLV and Related Viruses
Montreal, Canada. 26-30 June 2013
Background
HTLV-1 proviral load (PVL) is considered a risk marker
for diseases.
Methods
Quantification of HTLV-1 PVL was performed in 151
samples of 38 asymptomatic carriers (AC) collected at
different times during follow-up (6.1 to 14.8 years, mean
10) and in samples of five individuals who developed
HAM/TSP during follow-up (2.6 to 11.3 years, mean 7.2).
We used SYBR Green and number of proviral copies/
10,000 cells. Fluctuation of proviral load level was defined
at 0.5 log or more.
Results
PVL was stable in 52.6% (20/38) and floated in 47.4%
(18/38) subjects. In AC, the median of PVL in the 1st sam-
ple was 85 and in the last 59 (p = 0.59). Among those indivi-
duals with low PVL who showed fluctuation, it remained
low (£1%) in 77.8%. In 60% with high PVL who showed
fluctuation, it remained high during follow-up. 10 patients
developed HAM/TSP during the follow-up, and PVL was
quantified before and after in 5 cases. Median of PVL in the
1st sample was 445, and in the last sample 98 (p = 0.56). In
all cases, PVL was higher in the asymptomatic period,
declining after onset of HAM/TSP.
Conclusions
PVL reaches a plateau, characteristic of each individual; high
PVL appears to be followed by decrease and stabilization in
lower levels. Although PVL is supposedly a risk marker for
HAM/TSP, it had modest prognostic value in our cohort;
changes in clinical status and PVL did not coincide, besides
occurrence of high stable PVL in AC. Hemominas/FAPE-
MIG/DECIT/MS.
Authors’details
1
GIPH (Interdisciplinary HTLV Research Group); Hemominas, Belo Horizonte,
Minas Gerais, Brazil.
2
Faculdade da Saúde e Ecologia Humana (FASEH),
Vespasiano, Minas Gerais, Brazil.
Published: 7 January 2014
doi:10.1186/1742-4690-11-S1-P23
Cite this article as: Gonçalves et al.: Follow-up of HTLV-1 positive
individuals in the GIPH cohort (1997-2013): Proviral load was not a
prognostic marker for HAM/TSP. Retrovirology 2014 11(Suppl 1):P23.
Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
* Correspondence: gabrielaaseabra@gmail.com
1
GIPH (Interdisciplinary HTLV Research Group); Hemominas, Belo Horizonte,
Minas Gerais, Brazil
Full list of author information is available at the end of the article
Gonçalves et al.Retrovirology 2014, 11(Suppl 1):P23
http://www.retrovirology.com/content/11/S1/P23
© 2014 Gonçalves et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attri bution License (http://c reativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproductio n in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made availab le in this article, unless other wise stated.